Recent insights into the biological activities and drug delivery systems of tanshinones

References

• ZhouLZuoZChowMSDanshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical useJ Clin Pharmacol200545121345135916291709
   PubMed Web of Science ®Google Scholar
• WangXHMorris-NatschkeSLLeeKHNew developments in the chemistry and biology of the bioactive constituents of tanshenMed Res Rev200727113314816888751
   PubMed Web of Science ®Google Scholar
• TseAKChowKYCaoHHThe herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligandJ Biol Chem201328841299232993323986445
   PubMed Web of Science ®Google Scholar
• ChengTOCardiovascular effects of DanshenInt J Cardiol2007121192217363091
   PubMed Web of Science ®Google Scholar
• XuSLiuPTanshinone II-A: new perspectives for old remediesExpert Opin Ther Pat201323214915323231009
   PubMed Web of Science ®Google Scholar
• ParkJHParkOkChoJHAnti-inflammatory effect of tanshinone I in neuroprotection against cerebral ischemia-reperfusion injury in the gerbil hippocampusNeurochem Res20143971300131224760430
   PubMed Web of Science ®Google Scholar
• SuCCChenGWLinJGGrowth inhibition and apoptosis induction by tanshinone I in human colon cancer colo 205 cellsInt J Mol Med200822561361818949381
   PubMed Web of Science ®Google Scholar
• KimDHKimSJeonSJTanshinone I enhances learning and memory, and ameliorates memory impairment in mice via the extracellular signal-regulated kinase signalling pathwayBr J Pharmacol200915841131114219775283
   PubMed Web of Science ®Google Scholar
• TianXHWuJHTanshinone derivatives: a patent review (January 2006–September 2012)Expert Opin Ther Pat2013231192923094864
   PubMed Web of Science ®Google Scholar
• GaoSLiuZLiHLittlePJLiuPXuSCardiovascular actions and therapeutic potential of tanshinone IIAAtherosclerosis2012220131021774934
   PubMed Web of Science ®Google Scholar
• WangJWWuJYTanshinone biosynthesis in Salvia miltiorrhiza and production in plant tissue culturesAppl Microbiol Biotechnol201088243744920694462
   PubMed Web of Science ®Google Scholar
• WuWYWangYPPharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active componentsActa Pharmacol Sin20123391119113022941285
   PubMed Web of Science ®Google Scholar
• ZhouXChanKYeungJHHerb-drug interactions with Danshen (Salvia miltiorrhiza): a review on the role of cytochrome P450 enzymesDrug Metabol Drug Interact201227191822718621
   PubMedGoogle Scholar
• MaPLiuJZhangCLiangZRegulation of water-soluble phenolic acid biosynthesis in Salvia miltiorrhiza BungeAppl Biochem Biotechnol201317061253126223673485
   PubMed Web of Science ®Google Scholar
• WuWYYanHWangXBSodium tanshinone IIA silate inhibits high glucose-induced vascular smooth muscle cell proliferation and migration through activation of AMP-activated protein kinasePLoS One201494e9495724739942
   PubMed Web of Science ®Google Scholar
• ShangQXuHHuangLTanshinone IIA: a promising natural cardio-protective agentEvid Based Complement Alternat Med2012201271645922454677
   PubMed Web of Science ®Google Scholar
• LiuQYZhangZHJinXJiangYRJiaXBEnhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosanJ Pharm Pharmacol201365683984623647677
   PubMed Web of Science ®Google Scholar
• ZhangYWeiLSunDTanshinone IIA pretreatment protects myocardium against ischaemia/reperfusion injury through the phosphatidylinositol 3-kinase/Akt-dependent pathway in diabetic ratsDiabetes Obes Metab201012431632220380652
   PubMed Web of Science ®Google Scholar
• YuanXJingSWuLChenLFangJPharmacological postconditioning with tanshinone IIA attenuates myocardial ischemia-reperfusion injury in rats by activating the phosphatidylinositol 3-kinase pathwayExp Ther Med20148397397725120632
   PubMed Web of Science ®Google Scholar
• LiuZWangJHuangETanshinone IIA suppresses cholesterol accumulation in human macrophages: role of heme oxygenase-1J Lipid Res201455220121324302760
   PubMed Web of Science ®Google Scholar
• XuSLiuZHuangYTanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NF-kappaB activationTrans Res20121602114124
   Google Scholar
• ChenWTangFXieBChenSHuangHLiuPAmelioration of atherosclerosis by tanshinone IIA in hyperlipidemic rabbits through attenuation of oxidative stressEur J Pharmacol20126742–335936422088276
   PubMed Web of Science ®Google Scholar
• JinUHSuhSJChangHWTanshinone IIA from Salvia miltiorrhiza BUNGE inhibits human aortic smooth muscle cell migration and MMP-9 activity through AKT signaling pathwayJ Cell Biochem20081041152617979138
   PubMed Web of Science ®Google Scholar
• WangJDongMQLiuMLTanshinone IIA modulates pulmonary vascular response to agonist and hypoxia primarily via inhibiting Ca2+ influx and release in normal and hypoxic pulmonary hypertension ratsEur J Pharmacol20106401–312913820460121
   PubMed Web of Science ®Google Scholar
• LuoYXuDQDongHYTanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathwayPLoS One201382e5677423437233
   PubMed Web of Science ®Google Scholar
• ZhengLLiuMWeiMTanshinone IIA attenuates hypoxic pulmonary hypertension via modulating K currentsRespir Physiol Neurobiol201420512012825305099
   PubMedGoogle Scholar
• LiuLZhangXWangLThe neuroprotective effects of tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic strokeBrain Res Bull2010823–422823320417695
   PubMed Web of Science ®Google Scholar
• LeeJCParkJHParkOKNeuroprotective effects of tanshinone I from Danshen extract in a mouse model of hypoxia-ischemiaAnat Cell Biol201346318319024179693
   PubMedGoogle Scholar
• LamBYLoACSunXLuoHWChungSKSucherNJNeuroprotective effects of tanshinones in transient focal cerebral ischemia in micePhytomedicine200310428629112809358
   PubMed Web of Science ®Google Scholar
• YanFFLiuYFLiuYZhaoYXSulfotanshinone sodium injection could decrease fibrinogen level and improve clinical outcomes in patients with unstable angina pectorisInt J Cardiol2009135225425518790543
   PubMed Web of Science ®Google Scholar
• AdamsJDWangRYangJLienEJPreclinical and clinical examinations of Salvia miltiorrhiza and its tanshinones in ischemic conditionsChin Med20061317302964
   PubMedGoogle Scholar
• YuanSLWangXJWeiYQ丹參酮抗腫瘤作用及其機理的研究 [Anticancer effect of tanshinone and its mechanisms]Ai Zheng2003221213631366 Chinese14693071
   PubMedGoogle Scholar
• YunSMJungJHJeongSJSohnEJKimBKimSHTanshinone IIA induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR and p70 S6K in KBM-5 leukemia cellsPhytother Res201428345846423813779
   PubMed Web of Science ®Google Scholar
• ZhangYWeiRXZhuXBCaiLJinWHuHTanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG-63 cell line in vitroAnticancer Drugs201223221221922126901
   PubMedGoogle Scholar
• TsaiMYYangRCWuHTPangJHHuangSTAnti-angiogenic effect of tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cellsCancer Lett2011310219820621788102
   PubMed Web of Science ®Google Scholar
• YuxianXFengTRenLZhengcaiLTanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivoTumori200995678979520210245
   PubMed Web of Science ®Google Scholar
• ShanYFShenXXieYKInhibitory effects of tanshinone II-A on invasion and metastasis of human colon carcinoma cellsActa Pharmacol Sin200930111537154219820721
   PubMed Web of Science ®Google Scholar
• NizamutdinovaITLeeGWLeeJSTanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion moleculesCarcinogenesis200829101885189218586687
   PubMed Web of Science ®Google Scholar
• ZhangKLiJMengWXingHYangYC/EBPbeta and CHOP participate in tanshinone IIA-induced differentiation and apoptosis of acute promyelocytic leukemia cells in vitroInt J Hematol201092457157820981511
   PubMedGoogle Scholar
• WangJWangXJiangSGrowth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cellsJ Neurooncol2007821112116955220
   PubMed Web of Science ®Google Scholar
• LiangYYangYYuanS丹參酮IIA誘導原代培養人急性早幼粒細胞白血病細胞分化 [Terminal differentiation of human acute promyelocytic leukemia (APL) cells induced by tanshinone II A in primary culture]Hua Xi Yi Ke Da Xue Xue Bao2000312207210 Chinese12515138
   PubMedGoogle Scholar
• ChiuSCHuangSYChenSPSuCCChiuTLPangCYTanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivoProstate Cancer Prostatic Dis201316431532224042854
   PubMed Web of Science ®Google Scholar
• GongYLiYLuYBioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in miceInt J Cancer201112951042105220848589
   PubMed Web of Science ®Google Scholar
• HouLLXuQJHuGQXieSQ丹參酮IIA增強順鉑抗前列腺癌作用及分子機制研究 [Synergistic antitumor effects of tanshinone II A in combination with cisplatin via apoptosis in the prostate cancer cells]Yao Xue Xue Bao2013485675679 Chinese23888689
   PubMedGoogle Scholar
• ParkIJKimMJParkOJCryptotanshinone sensitizes DU145 prostate cancer cells to Fas(APO1/CD95)-mediated apoptosis through Bcl-2 and MAPK regulationCancer Lett20102981889820638780
   PubMed Web of Science ®Google Scholar
• ZhangGYangYMMengWTZhouJ丹參酮IIA與三氧化二砷協同誘導急性早幼粒白血病細胞凋亡的研究 [Apoptosis of NB4 cells induced by tanshinone II A combined with arsenic trioxide]Sichuan Da Xue Xue Bao Yi Xue Ban20104115761 Chinese20369471
   PubMedGoogle Scholar
• KanSCheungWMZhouYHoWSEnhancement of doxorubicin cytotoxicity by tanshinone IIA in HepG2 human hepatoma cellsPlanta Med2014801707624414309
   PubMed Web of Science ®Google Scholar
• SuCCTanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of P-gp and LC3-IIExp Ther Med20123355555922969929
   PubMed Web of Science ®Google Scholar
• FangZYLinRYuanBXYangGDLiuYZhangHTanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbitJ Ethnopharmacol2008115221722217997063
   PubMedGoogle Scholar
• ChenXZhouZWXueCCLiXXZhouSFRole of P-glycoprotein in restricting the brain penetration of tanshinone IIA, a major active constituent from the root of Salvia miltiorrhiza Bunge, across the blood-brain barrierXenobiotica200737663567817614009
   PubMed Web of Science ®Google Scholar
• HuTToKKWangLReversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhizaPhytomedicine201421111264127225172788
   PubMed Web of Science ®Google Scholar
• YangYMLiuT丹參酮IIA治療耐全反式維甲酸的急性早幼粒細胞白血病1例報道 [Complete remission of acute promyelocytic leukemia resisting all-trans retinoic acid of one case treated by tanshinone II A]Sichuan Da Xue Xue Bao Yi Xue Ban2006376965967 Chinese17236602
   PubMedGoogle Scholar
• ZhangYJiangPYeMKimSHJiangCLuJTanshinones: sources, pharmacokinetics and anti-cancer activitiesInt J Mol Sci20121310136211366623202971
   PubMed Web of Science ®Google Scholar
• FanGWGaoXMWangHThe anti-inflammatory activities of tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOSJ Steroid Biochem Mol Biol20091133–527528019429433
   PubMed Web of Science ®Google Scholar
• JangSIKimHJKimYJJeongSIYouYOTanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathwaysEur J Pharmacol20065421–31716797002
   PubMedGoogle Scholar
• ZhengSRenZZhangYQiaoYAnti-inflammatory mechanism research of tanshinone II A by module-based network analysisBiomed Mater Eng20142463815382425227098
   PubMedGoogle Scholar
• KimSYMoonTCChangHWSonKHKangSSKimHPEffects of tanshinone I isolated from Salvia miltiorrhiza bunge on arachidonic acid metabolism and in vivo inflammatory responsesPhytother Res200216761662012410540
   PubMed Web of Science ®Google Scholar
• KangBYChungSWKimSHRyuSYKimTSInhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorrhizaImmunopharmacology200049335536110996033
   PubMed Web of Science ®Google Scholar
• CaoEHLiuXQWangJJXuNFEffect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cellsFree Radic Biol Med19962068018068728027
   PubMed Web of Science ®Google Scholar
• LinRWangWRLiuJTYangGDHanCJProtective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanismJ Ethnopharmacol2006108221722216797899
   PubMed Web of Science ®Google Scholar
• LiYIElmerGLeboeufRCTanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidaseLife Sci20088315–1655756218762198
   PubMedGoogle Scholar
• TaoSZhengYLauATanshinone I activates the Nrf2-dependent antioxidant response and protects against As(III)-induced lung inflammation in vitro and in vivoAntioxid Redox Signal201319141647166123394605
   PubMedGoogle Scholar
• ZhouSChenWSuHZhengXProtective properties of tanshinone I against oxidative DNA damage and cytotoxicityFood Chem Toxicol20136240741224021569
   PubMedGoogle Scholar
• GuoYLiYXueLSalvia miltiorrhiza: an ancient Chinese herbal medicine as a source for anti-osteoporotic drugsJ Ethnopharmacol201415531401141625109459
   PubMed Web of Science ®Google Scholar
• LeeSYChoiDYWooERInhibition of osteoclast differentiation by tanshinones from the root of Salvia miltiorrhiza bungeArch Pharm Res200528890991316178416
   PubMed Web of Science ®Google Scholar
• KwakHBYangDHaHTanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1Exp Mol Med200638325626416819284
   PubMed Web of Science ®Google Scholar
• KimHHKimJHKwakHBInhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza BungeBiochem Pharmacol20046791647165615081864
   PubMed Web of Science ®Google Scholar
• JungSHSeolHJJeonSJSonKHLeeJRInsulin-sensitizing activities of tanshinones, diterpene compounds of the root of Salvia miltiorrhiza BungePhytomedicine200916432733519200697
   PubMedGoogle Scholar
• LeeDSLeeSHNohJGHongSDAntibacterial activities of cryptotanshinone and dihydrotanshinone I from a medicinal herb, Salvia miltiorrhiza BungeBiosci Biotechnol Biochem199963122236223910664860
   PubMed Web of Science ®Google Scholar
• RenYHoughtonPJHiderRCHowesMJNovel diterpenoid acetylcholinesterase inhibitors from Salvia miltiorrhizaPlanta Med200470320120415114495
   PubMed Web of Science ®Google Scholar
• WangXLeeWYOrPMYeungJHEffects of major tanshinones isolated from Danshen (Salvia miltiorrhiza) on rat CYP1A2 expression and metabolism of model CYP1A2 probe substratesPhytomedicine200916871272519403289
   PubMedGoogle Scholar
• YuCYeSSunHPXR-mediated transcriptional activation of CYP3A4 by cryptotanshinone and tanshinone IIAChem Biol Interact20091771586418805405
   PubMed Web of Science ®Google Scholar
• ParkJYKimJHKimYMTanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteasesBioorg Med Chem201220195928593522884354
   PubMed Web of Science ®Google Scholar
• ZhangHSChenXYWuTCZhangFJTanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathwayJ Cell Physiol201422991193120124414799
   PubMedGoogle Scholar
• YuXYLinSGZhouZWRole of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza BungeCurr Drug Metab20078432534017504222
   PubMed Web of Science ®Google Scholar
• FanLCTengHWShiauCWSHP-1 is a target of regorafenib in colorectal cancerOncotarget20145156243625125071018
   PubMedGoogle Scholar
• WangLLaiYLiCJiangXStudy on the intestinal absorption profiles of tanshinone IIA and its inclusion complex with cyclodextrin in ratsPDA J Pharm Sci Technol200963539040020158045
   PubMedGoogle Scholar
• LiuXAnCJinPLiuXWangLProtective effects of cationic bovine serum albumin-conjugated PEGylated tanshinone IIA nanoparticles on cerebral ischemiaBiomaterials201334381783023111336
   PubMedGoogle Scholar
• MaHFanQYuJXinJZhangCAnticancer activities of tanshinone microemulsion against hepatocellular carcinoma in vitro and in vivoMol Med Rep201371596423064251
   PubMed Web of Science ®Google Scholar
• YanHMZhangZHJiangYRDingDMSunEJiaXBAn attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188Pharmacogn Mag201410suppl 2S311S31724991109
   PubMedGoogle Scholar
• YuHSubediRKNepalPRKimYGChoiHKEnhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from Salvia miltiorrhizaArch Pharm Res20123581457146422941489
   PubMed Web of Science ®Google Scholar
• ZhangJHuangMGuanSA mechanistic study of the intestinal absorption of cryptotanshinone, the major active constituent of Salvia miltiorrhizaJ Pharmacol Exp Ther200631731285129416497784
   PubMed Web of Science ®Google Scholar
• HuLXingQMengJShangCPreparation and enhanced oral bioavailability of cryptotanshinone-loaded solid lipid nanoparticlesAAPS Pharm Sci Tech2010112582587
   PubMed Web of Science ®Google Scholar
• MalamYLoizidouMSeifalianAMLiposomes and nanoparticles: nanosized vehicles for drug delivery in cancerTrends Pharmacol Sci2009301159259919837467
   PubMed Web of Science ®Google Scholar
• ElbayoumiTATorchilinVPCurrent trends in liposome researchMethods Mol Biol201060512720072870
   PubMedGoogle Scholar
• IyerRReview of surfactant evaluation methods and perturbations of components in phases to predict onset of emulsion instabilityParticul Sci Technol2008264306317
   Web of Science ®Google Scholar
• MadeneAJacquotMScherJDesobrySFlavour encapsulation and controlled release – a reviewInt J Food Sci Technol2006411121
   Web of Science ®Google Scholar
• ChuTZhangQLiHDevelopment of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitroInt J Pharm20124241–2768822226873
   PubMedGoogle Scholar
• MaHFanQYuJXinJZhangCNovel microemulsion of tanshinone IIA, isolated from Salvia miltiorrhiza Bunge, exerts anticancer activity through inducing apoptosis in hepatoma cellsAm J Chin Med201341119721023336516
   PubMed Web of Science ®Google Scholar
• ChangLCWuCLLiuCWChuoWHLiPCTsaiTRPreparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsionsJ Biomed Nanotechnol20117455856721870460
   PubMed Web of Science ®Google Scholar
• McClementsDJNanoemulsion-based oral delivery systems for lipophilic bioactive components: nutraceuticals and pharmaceuticalsTher Deliv20134784185723883127
   PubMedGoogle Scholar
• LiangZMaoSJYinZNJinHLiHChuT丹參酮IIA靜脈乳劑的制備與質量評價 [Preparation and quality evaluation of intravenous tanshinone II (A) emulsion]Zhongguo Zhong Yao Za Zhi2008331112491252 Chinese18831197
   PubMedGoogle Scholar
• SolankiJNMurthyZVPControlled size silver nanoparticles synthesis with water-in-oil microemulsion method: a topical reviewInd Eng Chem Res201150221231112323
   Web of Science ®Google Scholar
• ShakeelFRamadanWFaisalMSTransdermal and topical delivery of anti-inflammatory agents using nanoemulsion/microemulsion: an updated reviewCurr Nanosci201062184198
   Google Scholar
• FanQFanGJYangPMZhaoJY丹參酮微乳逆轉腫瘤細胞多藥耐藥的研究 [Effect of tanshinone microemulsion on reversing MDR in human tumor cells]Zhongguo Zhong Yao Za Zhi2004291110791081 Chinese15656144
   PubMedGoogle Scholar
• LvHYFanQZhangNLiBY丹參酮微乳制劑的HPLC指紋圖譜研究 [Studies on HPLC fingerprints of tanshinone microemulsion]Zhongguo Zhong Yao Za Zhi2004291110471049 Chinese15656134
   PubMedGoogle Scholar
• LiHLZhangZYMaLLChenXY丹參酮微乳的制備及大鼠在體腸吸收 [Preparation of tanshinone microemulsion and its absorption in rat intestine in situ]Zhongguo Zhong Yao Za Zhi2007321110241027 Chinese17672333
   PubMedGoogle Scholar
• Laza-KnoerrALGrefRCouvreurPCyclodextrins for drug deliveryJ Drug Target201018964565620497090
   PubMed Web of Science ®Google Scholar
• YuexianFJunfenLChuanDPreparation and study on the inclusion complexes of two tanshinone compounds with beta-cyclodextrinSpectrochim Acta A Mol Biomol Spectrosc2005611–213514015556431
   PubMedGoogle Scholar
• LingWRuiLCHuaJXIn situ intestinal absorption behaviors of tanshinone IIA from its inclusion complex with hydroxypropyl-beta-cyclodextrinBiol Pharm Bull200730101918192217917262
   PubMedGoogle Scholar
• LuoXXuYHChenBGuLQHuangMLiuPQ羥丙基-β-環糊精對隱丹參酮的增溶作用及其包合物的制備 [Solubilization on cryptotanshinone by hydroxypropyl-beta-cyclodextrin and preparation of their inclusion compound]Zhongguo Zhong Yao Za Zhi2005301713281331 Chinese16323539
   PubMedGoogle Scholar
• ZhaoXLiuXGanLZhouCMoJPreparation and physicochemical characterizations of tanshinone IIA solid dispersionArch Pharm Res201134694995921725816
   PubMed Web of Science ®Google Scholar
• YuanJMaoSShenQHouSHeY載體聯用固體分散技術對丹參酮IIA體外溶出的影響 [Influence of solid dispersion technique combination on dissolution of tanshinone IIA]Zhongguo Zhong Yao Za Zhi2009346685689 Chinese19624004
   PubMedGoogle Scholar
• JiangYZhangZLuYTangJMaTJiaX丹參酮IIA二元載體固 體分散體的研究 [Study on solid dispersion of binary vector of tanshinone II A]Zhongguo Zhong Yao Za Zhi2012371013831387 Chinese22860446
   PubMedGoogle Scholar
• JiangYRZhangZHLiuQYHuSYChenXYJiaXBPreparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticlesInt J Nanomedicine201382285229323836971
   PubMed Web of Science ®Google Scholar
• JiangYRZhangZHXiaHJJiaXB基于共聚維酮的丹參酮IIA固體分散體的研究 [Study on solid dispersion of copovidone-based tanshinone II(A)]Zhongguo Zhong Yao Za Zhi2013382174178 Chinese23672037
   PubMedGoogle Scholar
• ChowJCBiswasPEatoughDNanoparticles and the environment – introductionJ Air Waste Manage2005556706707
   Web of Science ®Google Scholar
• GanLCHouSXBiYQWangCGWangXCChenQX2種方法制備丹參酮IIA-PLGA納米粒的比較 [Comparison of two preparation methods applied in tanshinone II(A)-loaded PLGA nanoparticles]Zhongguo Zhong Yao Za Zhi2007327578581 Chinese17583194
   PubMedGoogle Scholar
• LiangLChenYXiongSZengZSunMZhangH丹參酮IIA納米球對兔頸動脈球囊損傷后內膜增殖的抑制 [The inhibitive effect produced by local perfusion of tanshinone IIA nanoparticle on neointimal hyperplasia of rabbit carotid artery following intimal denudation]Sheng Wu Yi Xue Gong Cheng Xue Za Zhi2007244812816 Chinese17899751
   PubMedGoogle Scholar
• LiQWangYFengNFanZSunJNanYNovel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatomaJ Drug Target2008161072573219005937
   PubMed Web of Science ®Google Scholar
• ZhangWLLiuJPLiuXXChenZQStealth tanshinone IIA-loaded solid lipid nanoparticles: effects of poloxamer 188 coating on in vitro phagocytosis and in vivo pharmacokinetics in ratsYao Xue Xue Bao200944121421142821348419
   PubMedGoogle Scholar
• PrabhuRHPatravaleVBJoshiMDPolymeric nanoparticles for targeted treatment in oncology: current insightsInt J Nanomedicine2015101001101825678788
   PubMed Web of Science ®Google Scholar
• LiangXDZhengYFanTY丹參酮IIA脈沖微丸的制備與體外質 量評價 [Preparation and in vitro evaluation of tanshinone IIA pulsatile release pellets]Beijing Da Xue Xue Bao2010425559564 Chinese20957015
   PubMedGoogle Scholar
• ZhangJLiYFangXZhouDWangYChenMTPGS-g-PLGA/pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapyInt J Pharm20144761–218519825223472
   PubMed Web of Science ®Google Scholar
• LiJLiuPLiuJPZhangWLYangJKFanYQNovel tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluationEur J Pharm Biopharm201280242643222119664
   PubMedGoogle Scholar
• LiuPLiJLiuJYangJFanYRelease behavior of tanshinone IIA sustained-release pellets based on crack formation theoryJ Pharm Sci201210182811282022610467
   PubMedGoogle Scholar